Evaxion presents preclinical data on AML vaccine candidate
AI Summary
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
Channel NewsAsia —
Medical Xpress —
Medical Xpress —
Globo —
The Sydney Morning Herald —
Borneo Post —